Skip to content

Saturday, December 5th, 2009

Melissa Etheridge for Medical Marijuana

June 16, 2009 by Peggy Rowland  
Filed under Women's Health

Melissa Etheridge for Medical Marijuana

Melissa Etheridge recently interviewed with CNN’s Anderson Cooper on the topic of legalizing cannabis for medical purposes. She said that marijuana immediately eased the pain and nausea she felt during chemo treatments for breast cancer in 2004.
In the interview, she also said she continues to use marijuana now to help with acid reflux.
Currently, fewer than 15 US states permit marijuana to be taken for medical conditions, but there is no formal prescription, only a recommendation from doctors.
DrugPolicy.org notes that the Supreme Court ruled that the federal government can prosecute medical marijuana patients, even in states with “compassionate use laws” (2005 …read more

Pot/tobacco combo and serious lung risks

April 19, 2009 by Marijke Durning, RN  
Filed under Diseases & Conditions

Pot/tobacco combo and serious lung risks

If you smoke both marijuana and tobacco, you’re at an even higher risk of developing a serious lung disease, say researchers.
According to a study published in the Canadian Medical Association Journal last week, people who regularly smoked both tobacco and marijuana were about three times more likely than non-smokers to develop a COPD (chronic obstructive pulmonary disease), a serious lung disease. The authors wrote:
Smoking only tobacco was associated with an increased risk of COPD, as defined in all 3 ways. Smokers who reported using both marijuana and tobacco were almost 2.5 times more likely than nonsmokers to have respiratory symptoms …read more

Cannabis Compound Significantly Reduced Lung Cancer Tumor

April 19, 2007 by Gloria Gamat  
Filed under Diseases & Conditions

Cannabis Compound Significantly Reduced Lung Cancer Tumor

Delta-tetrahydrocannabinol (THC), the active compound in marijuana has been found to cut tumor growth by half in common lung cancer, aside from significantly reducing the ability of the cancer to spread.
Conducted by researchers at Harvard University, this is the first study to demonstrate that a cannabinoid compound inhibits EGF-induced growth and migration in epidermal growth factor receptor (EGFR) expressing non-small cell lung cancer cell lines.
According to Anju Preet, Ph.D., a researcher in the Division of Experimental Medicine:
“The beauty of this study is that we are showing that a substance of abuse, if used prudently, may offer a new road to …read more


About Us | Advertise with us | Blog for Blisstree | Privacy Policy | Terms of Use
Get This Theme | Sitemap


All content is Copyright © 2005-2009 b5media. All rights reserved.